Medplus Health Services Limited Earnings Summary — Q4 FY2025
MedPlus Reports Strong Q4 Earnings Growth with Net Profit Surging 53% YoY Amid Retail Expansion
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue has increased for 6 consecutive quarters.
- Revenue of ₹1,880 Cr is 21.8% higher year-on-year.
- Revenue has compounded at 10.9% annualised over the last 10 quarters.
- Revenue is at its highest level in 10 quarters.
- Net profit of ₹33 Cr is 21.7% below the same quarter last year.
- Profit growth is trailing revenue growth this quarter.
- Net profit has compounded at -0.3% annualised across the period.
- Operating margin stands at 7.1% in Q1 FY2027.
- Operating margin compressed by 138 bps year-on-year.
- Over the last two years operating margin has expanded by 79 bps.
- PBT margin is 2.2%.
- Expenses grew 23.7% against revenue growth of 21.8%.
- Operating profit of ₹133 Cr is 1.9% higher year-on-year.
- Operating leverage has been under pressure recently.
- 6 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 56/100 (Healthy) on the latest 10 quarters.
- Business momentum has softened and warrants monitoring.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Stable | 1,880 | 1,864 | 1,806 | 1,679 | 1,543 | 1,510 | 1,561 | 1,576 | 1,489 | 1,491 |
| Expenses | Stable | 1,746 | 1,695 | 1,648 | 1,530 | 1,412 | 1,373 | 1,429 | 1,452 | 1,395 | 1,385 |
| Operating Profit | Improving | 133 | 169 | 159 | 149 | 131 | 136 | 133 | 124 | 94 | 106 |
| Operating Margin | Stable | 7.1% | 9.1% | 8.8% | 8.9% | 8.5% | 9.0% | 8.5% | 7.9% | 6.3% | 7.1% |
| Other Income | Improving | 20 | 21 | 18 | 17 | 15 | 16 | 13 | 12 | 9 | 10 |
| Interest | Improving | 33 | 33 | 31 | 29 | 27 | 27 | 26 | 25 | 25 | 25 |
| Depreciation | Improving | 78 | 76 | 73 | 69 | 66 | 64 | 62 | 63 | 60 | 59 |
| Profit Before Tax | Volatile | 42 | 80 | 73 | 69 | 53 | 61 | 57 | 48 | 18 | 32 |
| Tax | Strong Uptrend | 9 | 16 | 16 | 13 | 10 | 10 | 11 | 9 | 3 | -2 |
| Net Profit | Volatile | 33 | 64 | 58 | 56 | 42 | 51 | 46 | 39 | 14 | 33 |
| Net Margin | Volatile | 1.8% | 3.4% | 3.2% | 3.3% | 2.8% | 3.4% | 2.9% | 2.5% | 1.0% | 2.2% |
Key Takeaways
- Q4 FY2025 Net Profit witnessed significant year-on-year growth of 52.9%, reaching ₹513.2 million.
- The Diagnostic Services segment continues to show strong momentum, with Q4 revenue rising 20.9% YoY to ₹280.8 million.
- Operational leverage is improving as EBITDA margins expanded despite a slight sequential dip in total revenue.
- The company successfully completed the allotment of 49,593 equity shares under its 2021 ESOP plan during the quarter.
- MedPlus maintained its footprint with over 4,900 stores, focusing on cluster-based expansion in Tier-2 and Tier-3 cities.
- Consolidated Profit Before Tax (PBT) for the full year FY2025 more than doubled to ₹1,832.9 million compared to FY2024.
- Non-retail segments (Diagnostics) narrowed their operating losses significantly, contributing to overall profitability gains.
Management Guidance
Management remains focused on deepening penetration in Southern and Western India through its omni-channel approach and private label expansion. While dividends haven't been initiated, the focus is on utilizing cash for aggressive store rollouts and supply chain optimization.
Sentiment Shift
Improving
The consistent expansion of operating margins and the sharp reduction in diagnostic segment losses indicate that the company is successfully capturing economies of scale.
Outlook
The outlook remains strong as store-level efficiencies outpace corporate overheads. Management appears confident in navigating competitive pressures from e-pharmacies while maintaining 12-18% revenue growth trajectories.
From the Annual Report (Key Quotes)
“Give a true and fair view... of consolidated net profit... for the year ended 31 March 2025.”
“The unutilized IPO proceeds amounting to 669.10 million are held in fixed deposits and escrow.”
“Diagnostics services segment results improved from a loss of ₹59.8 million in the prior year's quarter to a loss of ₹9.0 million this quarter.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Medplus Health Services Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.